For: | Guan YS, Sun L, Zhou XP, Li X, Zheng XH. Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up. World J Gastroenterol 2004; 10(24): 3543-3548 [PMID: PMC4611989 DOI: 10.3748/wjg.v10.i24.3543] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i24/3543.htm |
Number | Citing Articles |
1 |
Alex Kirkham. Imaging and Focal Therapy of Early Prostate Cancer. Current Clinical Urology 2017; : 431 doi: 10.1007/978-3-319-49911-6_33
|
2 |
Won-Hyeong Park, Ju-Hyun Shim, Seung-Bong Han, Hyung-Jin Won, Yong-Moon Shin, Kang-Mo Kim, Young-Suk Lim, Han-Chu Lee. Clinical Utility of Des-γ-Carboxy Prothrombin Kinetics as a Complement to Radiologic Response in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology 2012; 23(7): 927 doi: 10.1016/j.jvir.2012.04.021
|
3 |
P. Cascales Campos, P. Ramirez, R. Gonzalez, B. Febrero, J.A. Pons, M. Miras, F. Sanchez Bueno, R. Robles, P. Parrilla. Value of 18-FDG-Positron Emission Tomography/Computed Tomography Before and After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation: Initial Results. Transplantation Proceedings 2011; 43(6): 2213 doi: 10.1016/j.transproceed.2011.05.023
|
4 |
Andreea-Elena Scheau, Sandra Oana Jurca, Cristian Scheau, Ioana Gabriela Lupescu. Non-Surgical Treatment for Hepatocellular Carcinoma: What to Expect at Follow-Up Magnetic Resonance Imaging—A Pictorial Review. Applied Sciences 2024; 14(20): 9159 doi: 10.3390/app14209159
|
5 |
|
6 |
Davide Ippolito, Davide Fior, Cammillo Talei Franzesi, Cristina Capraro, Alessandra Casiraghi, Davide Leni, Francesco Vacirca, Rocco Corso, Sandro Sironi. Tumour-related neoangiogenesis: Functional dynamic perfusion computed tomography for diagnosis and treatment efficacy assessment in hepatocellular carcinoma. Digestive and Liver Disease 2014; 46(10): 916 doi: 10.1016/j.dld.2014.06.002
|
7 |
Marie Van de Putte, Huaijun Wang, Feng Chen, Peter A.M. de Witte, Yicheng Ni. Hypericin as a Marker for Determination of Tissue Viability After Intratumoral Ethanol Injection in a Murine Liver Tumor Model. Academic Radiology 2008; 15(1): 107 doi: 10.1016/j.acra.2007.08.008
|
8 |
R. Farina, F. Pennisi, G. Mazzone, M. Pennisi, G. Riva, P. V. Foti, C. Puglisi, G. C. Ettorre. Power Doppler ultrasonography with time-signal intensity curves in monitoring hepatocellular carcinoma and liver metastases after intralesional therapy. La radiologia medica 2009; 114(1): 32 doi: 10.1007/s11547-008-0324-z
|
9 |
Davide Ippolito, Davide Fior, Pietro Andrea Bonaffini, Cristina Capraro, Davide Leni, Rocco Corso, Sandro Sironi. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients. European Journal of Radiology 2014; 83(9): 1665 doi: 10.1016/j.ejrad.2014.05.040
|
10 |
Zigeng Zhang. MRI monitoring of combined therapy with transcatheter arterial delivery of NK cells and systemic administration of sorafenib for the treatment of HCC. American Journal of Cancer Research 2024; 14(5): 2216 doi: 10.62347/IARO1564
|
11 |
M. Ravaioli, G.L. Grazi, F. Piscaglia, F. Trevisani, M. Cescon, G. Ercolani, M. Vivarelli, R. Golfieri, A. D’Errico Grigioni, I. Panzini, C. Morelli, M. Bernardi, L. Bolondi, A.D. Pinna. Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria. American Journal of Transplantation 2008; 8(12): 2547 doi: 10.1111/j.1600-6143.2008.02409.x
|
12 |
Long Sun, Yong-Song Guan, Wei-Min Pan, Zuo-Ming Luo, Ji-Hong Wei, Long Zhao, Hua Wu. Metabolic restaging of hepatocellular carcinoma using whole-body <sup>18</sup>F-FDG PET/CT. World Journal of Hepatology 2009; 1(1): 90-97 doi: 10.4254/wjh.v1.i1.90
|
13 |
Anum Aslam, Richard Kinh Gian Do, Avinash Kambadakone, Bradley Spieler, Frank H Miller, Ahmed M Gabr, Resmi A Charalel, Charles Y Kim, David C Madoff, Mishal Mendiratta-Lala. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions. World Journal of Hepatology 2020; 12(10): 738-753 doi: 10.4254/wjh.v12.i10.738
|
14 |
Anum Aslam, Amita Kamath, Bradley Spieler, Mark Maschiocchi, Carl F. Sabottke, Victoria Chernyak, Sara C. Lewis. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents. Abdominal Radiology 2021; 46(8): 3565 doi: 10.1007/s00261-021-03076-x
|
15 |
Peter S. Liu, Ajaykumar C. Morani, Hero K. Hussain. Primary Carcinomas of the Liver. 2009; : 122 doi: 10.1017/CBO9780511770807.011
|
16 |
Evangelos Chartampilas, Vasileios Rafailidis, Vivian Georgopoulou, Georgios Kalarakis, Adam Hatzidakis, Panos Prassopoulos. Current Imaging Diagnosis of Hepatocellular Carcinoma. Cancers 2022; 14(16): 3997 doi: 10.3390/cancers14163997
|
17 |
Hye Ok Kim, Jae Seung Kim, Yong Moon Shin, Jin-Sook Ryu, Yung Sang Lee, Seung Gyu Lee. Evaluation of Metabolic Characteristics and Viability of Lipiodolized Hepatocellular Carcinomas Using18F-FDG PET/CT. Journal of Nuclear Medicine 2010; 51(12): 1849 doi: 10.2967/jnumed.110.079244
|
18 |
Seok Ling Ong, Gianpiero Gravante, Matthew S. Metcalfe, Andrew D. Strickland, Ashley R. Dennison, David M. Lloyd. Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review. European Journal of Gastroenterology & Hepatology 2009; 21(6): 599 doi: 10.1097/MEG.0b013e328318ed04
|
19 |
Michael M. Awad, Lara Devgan, Ihab R. Kamel, Michael Torbensen, Michael A. Choti. Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings. HPB 2007; 9(5): 357 doi: 10.1080/13651820701646222
|
20 |
Xiaojun Qi, Haibo Shao, Jian Zhang, Ziping Sun, Yicheng Ni, Ke Xu. Radiopharmaceutical study on Iodine-131-labelled hypericin in a canine model of hepatic RFA-induced coagulative necrosis. La radiologia medica 2015; 120(2): 213 doi: 10.1007/s11547-014-0433-9
|
21 |
Rony Kampalath, Karen Tran-Harding, Richard K.G. Do, Mishal Mendiratta-Lala, Vahid Yaghmai. Evaluation of Hepatocellular Carcinoma Treatment Response After Locoregional Therapy. Magnetic Resonance Imaging Clinics of North America 2021; 29(3): 389 doi: 10.1016/j.mric.2021.05.013
|
22 |
Nicolas Voizard, Milena Cerny, Anis Assad, Jean-Sébastien Billiard, Damien Olivié, Pierre Perreault, Ania Kielar, Richard K. G. Do, Takeshi Yokoo, Claude B. Sirlin, An Tang. Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review. Insights into Imaging 2019; 10(1) doi: 10.1186/s13244-019-0801-z
|
23 |
J.O. Lee, K.W. Lee, D.Y. Oh, J.H. Kim, S.A. Im, T.Y. Kim, Y.J. Bang. Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. Annals of Oncology 2009; 20(8): 1402 doi: 10.1093/annonc/mdp010
|
24 |
Logain Nabil Salem, Dina Moghazy Mohammed, Dina Hazem Ziada, M.H. Elshafey. Dual input computed tomography perfusion in evaluating the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(3): 597 doi: 10.1016/j.ejrnm.2018.01.017
|
25 |
Richa Patel, Anum Aslam, Neehar D. Parikh, Benjamin Mervak, Eman Mubarak, Lily Higgins, Kayli Lala, Jack F. Conner, Valerie Khaykin, Mustafa Bashir, Richard Kinh Gian Do, Lauren M. B. Burke, Elainea N. Smith, Charles Y. Kim, Kimberly L. Shampain, Dawn Owen, Mishal Mendiratta‐Lala. Updates on LI‐RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI. Journal of Magnetic Resonance Imaging 2023; 57(6): 1641 doi: 10.1002/jmri.28659
|
26 |
Ji Young Lee, Young-sun Kim, Hyunchul Rhim, Hyo K. Lim, Dongil Choi, Won Jae Lee. Pattern and Chronological Change of Iodized Oil Retention in Radiofrequency Ablation-Induced Vascular Injury Area. Journal of Computer Assisted Tomography 2010; 34(3): 354 doi: 10.1097/RCT.0b013e3181cbf43a
|
27 |
Andrea S. Kierans, Mohamed Elazzazi, Larissa Braga, Polytimi Leonardou, David A. Gerber, Charles Burke, Waqas Qureshi, Masayuki Kanematsu, Richard C. Semelka. Thermoablative Treatments for Malignant Liver Lesions: 10-Year Experience of MRI Appearances of Treatment Response. American Journal of Roentgenology 2010; 194(2): 523 doi: 10.2214/AJR.09.2621
|
28 |
Robert M. Eisele, Guido Schumacher, Enrique Lopez-Hänninen, Peter Neuhaus. Role of B-mode ultrasound screening in detection of local tumor recurrence in the first year after radiofrequency ablation in the liver. Cancer Detection and Prevention 2007; 31(4): 316 doi: 10.1016/j.cdp.2007.07.002
|
29 |
Alexander P. S. Kirkham, Mark Emberton, Ivan M. Hoh, Rowland O. Illing, A. Alex Freeman, Clare Allen. MR Imaging of Prostate after Treatment with High-Intensity Focused Ultrasound. Radiology 2008; 246(3): 833 doi: 10.1148/radiol.2463062080
|
30 |
Gerhild Becker, Tarik Soezgen, Manfred Olschewski, Joerg Laubenberger, Hubert Erich Blum, Hans-Peter Allgaier. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World Journal of Gastroenterology 2005; 11(39): 6104-6109 doi: 10.3748/wjg.v11.i39.6104
|
31 |
Haohao Lu, Chuansheng Zheng, Bin Liang, Xiangwen Xia, Hongjie Fan. Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1280837
|
32 |
Davide Ippolito, Anna Pecorelli, Giulia Querques, Silvia Girolama Drago, Cesare Maino, Cammillo Talei Franzesi, Adam Hatzidakis, Sandro Sironi. Dynamic Computed Tomography Perfusion Imaging: Complementary Diagnostic Tool in Hepatocellular Carcinoma Assessment From Diagnosis to Treatment Follow-up. Academic Radiology 2019; 26(12): 1675 doi: 10.1016/j.acra.2019.02.010
|
33 |
Nayelli Ortega López. PET/Computed Tomography in Evaluation of Transarterial Chemoembolization. PET Clinics 2015; 10(4): 507 doi: 10.1016/j.cpet.2015.05.006
|
34 |
Yi-Jun Liang, Haoyao Wang, Hui Yu, Guodong Feng, Fang Liu, Ming Ma, Yu Zhang, Ning Gu. Magnetic navigation helps PLGA drug loaded magnetic microspheres achieve precise chemoembolization and hyperthermia. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2020; 588: 124364 doi: 10.1016/j.colsurfa.2019.124364
|
35 |
Dahae Lee, Seungjo Park, Mary Jasmin C. Ang, Jun-Gyu Park, Sooa Yoon, Cheolhyun Kim, Sang-kwon Lee, Kyoung-oh Cho, Jihye Choi. Evaluation of liver lesions by use of shear wave elastography and computed tomography perfusion imaging after radiofrequency ablation in clinically normal dogs. American Journal of Veterinary Research 2018; 79(11): 1140 doi: 10.2460/ajvr.79.11.1140
|
36 |
Nikita Consul, Claude B. Sirlin, Victoria Chernyak, David T. Fetzer, William R. Masch, Sandeep S. Arora, Richard K. G. Do, Robert M. Marks, Kathryn J. Fowler, Amir A. Borhani, Khaled M. Elsayes. Imaging Features at the Periphery: Hemodynamics, Pathophysiology, and Effect on LI-RADS Categorization. RadioGraphics 2021; 41(6): 1657 doi: 10.1148/rg.2021210019
|
37 |
Wei-Zhu Yang, Na Jiang, Ning Huang, Jing-Yao Huang, Qu-Bin Zheng, Quan Shen. Combined therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation for small hepatocellular carcinoma. World Journal of Gastroenterology 2009; 15(6): 748-752 doi: 10.3748/wjg.15.748
|
38 |
Susan M. Weeks, Charles Burke. Local Therapeutic Treatments for Focal Liver Disease. Radiologic Clinics of North America 2005; 43(5): 899 doi: 10.1016/j.rcl.2005.05.003
|
39 |
Davide Ippolito, Pietro Andrea Bonaffini, Cristina Capraro, Davide Leni, Rocco Corso, Sandro Sironi. Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion. Abdominal Imaging 2013; 38(3): 502 doi: 10.1007/s00261-012-9924-0
|
40 |
Ju Hyun Shim, Seungbong Han, Yong Moon Shin, Eunsil Yu, Wonhyeong Park, Kang Mo Kim, Young-Suk Lim, Han Chu Lee. Optimal Measurement Modality and Method for Evaluation of Responses to Transarterial Chemoembolization of Hepatocellular Carcinoma Based on Enhancement Criteria. Journal of Vascular and Interventional Radiology 2013; 24(3): 316 doi: 10.1016/j.jvir.2012.10.022
|
41 |
Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography. Diagnostic and Interventional Imaging 2017; 98(3): 253 doi: 10.1016/j.diii.2016.09.002
|
42 |
Marielia Gerena, Christopher Molvar, Mark Masciocchi, Sadhna Nandwana, Carl Sabottke, Bradley Spieler, Rishi Sharma, Leo Tsai, Ania Kielar. LI-RADS treatment response assessment of combination locoregional therapy for HCC. Abdominal Radiology 2021; 46(8): 3634 doi: 10.1007/s00261-021-03165-x
|
43 |
Hossein Ghanaati, Seyed Moayed Alavian, Ali Jafarian, Nasser Ebrahimi Daryani, Mohsen Nassiri-Toosi, Amir Hossein Jalali, Madjid Shakiba. Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence. Iranian Journal of Radiology 2012; 9(4): 167 doi: 10.5812/iranjradiol.8242
|
44 |
Donglin Kuang, Nan Zhang, Mengfan Zhang, Hao Li, Xinwei Han, Jianzhuang Ren, Xuhua Duan. Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.957710
|
45 |
Stephan Zangos, Katrin Eichler, Jörn O. Balzer, Ralf Straub, Renate Hammerstingl, Christopher Herzog, Thomas Lehnert, Mathias Heller, Axel Thalhammer, Martin G. Mack, Thomas J. Vogl. Large-sized hepotocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). European Radiology 2007; 17(2): 553 doi: 10.1007/s00330-006-0343-x
|